Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1125 of 2873 entries
View as:

Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00411593 Org: User:
Start: 11/30/06 End: 05/31/07 Due: 05/31/08

MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)

Phase: N/A Priority: Normal
NCT ID: NCT03469284 Org: User:
Start: 02/28/19 End: 02/03/22 Due: 02/03/23

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00790452 Org: User:
Start: 11/30/08 End: 10/31/09 Due: 10/31/10

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01538472 Org: User:
Start: 09/30/03 End: 11/30/11 Due: 11/30/12

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05177796 Org: User:
Start: 03/11/22 End: 07/26/23 Due: 07/26/24

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

Phase: N/A Priority: Normal
NCT ID: NCT04754412 Org: User:
Start: 07/23/21 End: 04/01/26 Due: 04/01/27

Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

Phase: N/A Priority: Normal
NCT ID: NCT04776850 Org: User:
Start: 12/29/20 End: 12/05/22 Due: 12/05/23

Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00695786 Org: User:
Start: 06/10/08 End: 07/11/20 Due: 07/11/21

Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06046482 Org: User:
Start: 11/28/23 End: 08/26/24 Due: 08/26/25

Quit4Health Intervention in Supporting Smoking Cessation and Preventing Smoking Initiation in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT04009590 Org: User:
Start: 12/10/18 End: 01/19/21 Due: 01/19/22

Correlation of MR Thermal Imaging to Actual Size of Ablation During Laser Ablation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00688038 Org: User:
Start: 05/13/08 End: 09/12/17 Due: 09/12/18

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01725165 Org: User:
Start: 11/28/12 End: 05/08/24 Due: 05/08/25

Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)

Phase: N/A Priority: Normal
NCT ID: NCT00887068 Org: User:
Start: 04/21/09 End: 08/20/18 Due: 08/20/19

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00038142 Org: User:
Start: 11/30/97 End: 03/31/16 Due: 03/31/17

Methylphenidate and a Nursing Telephone Intervention for Fatigue

Phase: N/A Priority: Normal
NCT ID: NCT00424099 Org: User:
Start: 01/09/07 End: 11/22/21 Due: 11/22/22

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Phase: N/A Priority: Normal
NCT ID: NCT01782976 Org: User:
Start: 06/30/13 End: - Due: -

Study of Curcumin, Vorinostat, and Sorafenib

Phase: N/A Priority: Normal
NCT ID: NCT01608139 Org: User:
Start: 11/30/12 End: - Due: -

Cardiac Biomarkers in Early Detection of Cardiotoxicity in Patients Receiving Sunitinib or Sorafenib Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00532064 Org: User:
Start: 09/12/07 End: 05/02/18 Due: 05/02/19

Measuring Non-Enhancing Glioblastoma Progression

Phase: N/A Priority: Normal
NCT ID: NCT00777686 Org: User:
Start: 08/31/08 End: 03/31/11 Due: 03/31/12

Delirium Recall in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00493714 Org: User:
Start: 07/31/05 End: 12/31/07 Due: 12/31/08

Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00050167 Org: User:
Start: 11/30/02 End: 08/31/11 Due: 08/31/12

EBUS TBNA After PET/CT in Diagnosing Patients With Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02719847 Org: User:
Start: 03/18/16 End: 03/31/26 Due: 03/31/27

Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00383994 Org: User:
Start: 09/30/06 End: 07/22/19 Due: 07/22/20

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

Phase: N/A Priority: Normal
NCT ID: NCT02378701 Org: User:
Start: 02/28/15 End: 07/18/22 Due: 07/18/23

Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00113217 Org: User:
Start: 02/28/05 End: 08/31/12 Due: 08/31/13